查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1974092

细胞培养基袋市场：依产品类型、细胞类型、包装形式和应用划分－全球预测，2026-2032年

Cell Culture Media Bags Market by Product Type, Cell Type, Packaging Mode, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，细胞培养基袋市场价值将达到 13.2 亿美元，到 2026 年将成长至 14.3 亿美元，到 2032 年将达到 25.3 亿美元，复合年增长率为 9.67%。

主要市场统计数据
基准年 2025 13.2亿美元
预计年份：2026年 14.3亿美元
预测年份：2032年 25.3亿美元
复合年增长率 (%) 9.67%

简洁且权威的介绍，概述了重组细胞培养基袋的选择和采用的运作和技术驱动因素。

细胞培养基袋领域正处于生物製程创新、一次性技术应用和不断变化的监管要求的交汇点。近年来，培养基袋设计、材料相容性和无菌保证方面的技术进步，以及对灵活生物製造平台日益增长的需求，共同为研发人员和终端用户创造了一个充满活力的环境。本报告的执行层面概述对影响现代细胞培养工作流程中产品选择、适用性和供应链策略的关键营运、技术和商业因素进行了全面分析。

技术进步和更严格的法规如何共同改变人们对一次性培养基供应系统的采购、验证和伙伴关係的预期？

过去几年，细胞培养基供应格局发生了翻天覆地的变化，这主要得益于跨领域的创新和用户需求的不断变化。一次性聚合物技术的进步提高了材料的性能和相容性，使其在敏感的哺乳动物细胞和昆虫细胞应用中得到更广泛的应用。同时，随着封闭式系统工作流程的日益成熟，能够支持无菌转移、最大限度减少顶部空间氧气暴露以及与上下游设备可靠连接的培养袋设计的重要性也日益凸显。

近期关税调整对生物製造耗材筹资策略、供应连续性和本地合格选择的实际影响。

2025年实施的新关税措施为细胞培养基袋的全球采购和供应商选择策略带来了新的复杂性。关税调整改变了进口聚合物组件和一次性成品组件的相对经济效益，促使企业重新评估供应商的选址和物流模式。为此，许多采购团队开始进行情境规划，以了解诸如到岸成本波动、前置作业时间延长以及潜在的供应商整合等营运影响。

可操作的细分主导洞察，将产品类型、应用重点、细胞谱系和包装模式与采购和验证优先事项连结起来。

为了使产品开发和采购重点与最终用户需求保持一致，清晰了解产品和应用细分至关重要。依产品类型划分，市场分为二维培养袋和三维培养袋，前者是针对传统平面製程优化的设备，后者是专为高容量培养或骨架培养而设计的设备。按应用划分，市场分为生物製药生产和研发两大领域。生物製药生产领域进一步细分为单株抗体生产、重组蛋白生产和疫苗生产。研发领域则分为生物製程开发、单株抗体研究和干细胞研究。这种细分方式阐明了最终用户如何根据製程阶段优先考虑无菌保证、可扩展性和材料相容性等属性。

区域趋势和监管差异是影响全球生物製造地供应商选择、库存策略和业务永续营运的关键因素。

在细胞培养基袋领域，区域因素持续影响策略重点、供应商选择和法规遵循。在美洲，对先进生物製药开发和契约製造的投资推动了对检验且可扩展的一次性使用系统的需求。该地区的企业往往优先考虑快速临床部署和一体化的供应商服务。同时，在欧洲、中东和非洲，复杂的法规环境以及对合规文件和标准化品质系统的高度重视，促使供应商提供先进的技术文件和特定区域的法规支援。

供应商的透明度、材料专业知识和整合服务模式，在一次性培养基供应解决方案中创造了竞争优势。

细胞培养基袋生态系统中的领先供应商透过技术文件、材料科学专业知识和整合服务的组合来脱颖而出。投资于全面的提取和洗脱测试、一致性矩阵以及强大的供应链可追溯性的公司，在与受监管的製造商和合约组织合作时，能够获得明显的优势。这些能力减轻了客户下游验证的负担，并支援在生产关键应用中的快速部署。

为培养基供应系统的使用者提供实用有效的建议，以增强供应商的韧性，提高验证效率，并提高营运灵活性。

产业领导者应采取切实可行的方案，在提升即时营运韧性的同时，兼顾策略能力建构。首先，应优先考虑在不同地区建立多元化的认证供应商网络，以降低单一故障点所带来的风险。使供应商认证时间表与区域监管要求保持一致，将有助于加快并行采购流程，避免返工。其次，应投入资源进行深入的技术实质审查，重点关注萃取物/浸出液特性、材料相容性和连接器互通性，以最大程度地减少製程转型和规模化生产过程中可能出现的意外问题。

我们严谨的混合方法研究途径，结合技术访谈、材料评估和供应商文件的交叉检验，为实际决策提供支援。

本报告的调查方法结合了对技术和采购经理的访谈、对材料科学文献的全面回顾以及对供应商技术文件的交叉检验，以确保研究结果的可靠性。主要资料收集工作包括对製程开发科学家、品质保证经理和采购专家进行结构化访谈，以了解与容器选择和认证相关的实际限制和优先事项。此外，还对公开的技术报告和监管指导文件进行了详细分析，以检验检验和文件记录实践，从而补充了这些定性证据。

主要结论强调了技术检验在决策、供应商透明度和供应链韧性方面的综合重要性。

总而言之，包装袋设计、材料科学和监管要求的进步正在重塑组织选择和认证培养基供应系统的方式。如今，技术性能、文件严谨性和供应链配置的相互作用与产品规格一样，都对营运准备就绪起着决定性作用。因此，采购决策需要从全面观点出发，包括合规性测试、供应商透明度、区域认证要求和紧急时应对计画。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 细胞培养基袋市场：依产品类型划分

  • 2D包
  • 3D袋

第九章：细胞培养基袋市场：依细胞类型划分

  • 昆虫
  • 哺乳动物
    • CHO
    • 融合瘤
    • NS0

第十章 细胞培养基袋市场：依包装类型划分

  • 散装袋
  • 一次性预填充装袋

第十一章：细胞培养基袋市场：依应用划分

  • 生物製药生产
    • 单株抗体生产
    • 重组蛋白生产
    • 疫苗生产
  • 研究与开发
    • 生物製程开发
    • 单株抗体研究
    • 干细胞研究

第十二章 细胞培养基袋市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 细胞培养基袋市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 细胞培养基袋市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国细胞培养基袋市场

第十六章：中国细胞培养基袋市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Avantor, Inc.
  • BIOPAC
  • CellBios Healthcare & Lifesciences Pvt Ltd
  • Corning Incorporated
  • Danaher Corporation
  • Entegris, Inc.
  • Eppendorf AG
  • FUJIMORI KOGYO Co., Ltd.
  • Greiner Bio-One International GmbH
  • Lonza Group AG
  • Meissner Filtration Products, Inc.
  • Merck KGaA
  • OriGen Biomedical, Inc.
  • Parker Hannifin Corporation
  • PBS BIoTech, LLC
  • Repligen Corporation
  • Saint-Gobain Life Sciences
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
  • Tofflon Life Science Co., Ltd.
Product Code: MRR-5D340F440B75

The Cell Culture Media Bags Market was valued at USD 1.32 billion in 2025 and is projected to grow to USD 1.43 billion in 2026, with a CAGR of 9.67%, reaching USD 2.53 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.32 billion
Estimated Year [2026] USD 1.43 billion
Forecast Year [2032] USD 2.53 billion
CAGR (%) 9.67%

A concise authoritative introduction that frames the operational and technological drivers reshaping selection and adoption of cell culture media bags

The cell culture media bags sector is at the intersection of bioprocess innovation, single-use technology adoption, and evolving regulatory expectations. Recent technological refinements in bag design, materials compatibility, and sterility assurance have converged with heightened demand for flexible biomanufacturing platforms to create a dynamic environment for developers and end users alike. This report's executive-level overview synthesizes the key operational, technological, and commercial forces influencing product selection, application suitability, and supply chain strategies in contemporary cell culture workflows.

Stakeholders across biopharmaceutical production and research organizations are navigating a landscape that rewards nimble supply arrangements and validated single-use solutions. As organizations increasingly prioritize speed to clinic, product quality, and process reproducibility, packaging and handling considerations have gained prominence alongside standard performance metrics. The introduction of more complex cell formats and higher-value biologics places exacting demands on media delivery systems, driving attention to compatibility, extractables and leachables profiles, and closed-system integration.

The summary that follows distills these multifaceted dynamics into actionable insights for leaders seeking to align procurement, development, and manufacturing strategies with emerging best practices. Throughout, emphasis is placed on practical implications for product selection and operational adaptation rather than abstract projections, enabling decision-makers to identify priorities for immediate and medium-term initiatives.

How technological advances and regulatory rigor are jointly rewriting procurement, validation, and partnership expectations for single-use media delivery systems

Over the past several years, the environment for cell culture media delivery has undergone transformative shifts driven by cross-cutting innovations and changing user expectations. Advances in single-use polymer technologies have improved material performance and compatibility, enabling broader acceptance across sensitive mammalian and insect cell applications. At the same time, the maturation of closed-system workflows has elevated the importance of bag design that supports aseptic transfer, minimal headspace oxygen exposure, and reliable connectivity to upstream and downstream equipment.

Procurement and manufacturing groups have responded to these engineering improvements by prioritizing supplier collaboration and enhanced documentation to expedite validation programs. Regulatory agencies have also increased scrutiny on component qualification and extractables/leachables characterization, prompting vendors to invest in more rigorous testing protocols and clearer technical dossiers. Concurrently, end users are seeking modular and scalable solutions that permit rapid scale-up without compromising reproducibility or contaminant control.

These transformative shifts have altered how organizations evaluate value: product durability and upfront cost are being balanced against lifecycle risk, operational flexibility, and time-to-deliverables. As processes become more complex, interoperability and supplier transparency have emerged as non-negotiable attributes. Decisions are increasingly informed by direct compatibility data, real-world user validation, and risk-based approaches to component selection, which together are recalibrating procurement criteria and partnership models.

Practical implications of recent tariff adjustments on sourcing strategies, supply continuity, and local qualification choices for biomanufacturing consumables

The introduction of new tariff measures in 2025 has introduced tangible complexity into global sourcing and vendor selection strategies for cell culture media bags. Tariff adjustments have altered the comparative economics of importing polymer components and finished single-use assemblies, encouraging organizations to re-evaluate supplier footprints and logistics models. In response, many procurement teams have initiated scenario planning to understand the operational implications of shifted landed costs, longer lead times, and potential supplier consolidation.

Beyond immediate cost considerations, tariffs affect decisions about where to qualify suppliers and how to structure multi-supplier strategies. Organizations that previously optimized around lowest unit cost are shifting focus toward supply chain resilience, local regulatory alignment, and reduced cross-border dependencies. This recalibration is influencing both long-term sourcing and near-term inventory practices, as buyers weigh holding additional safety stock against the operational costs of extended storage and material shelf-life constraints.

Tariff-driven changes are also accelerating partnerships with regional contract manufacturers and packaging specialists who can provide shorter lead times and localized regulatory support. Such collaborations support faster qualification cycles and mitigate exposure to customs-related delays. From a strategic standpoint, firms that proactively reassess supplier risk, diversify sourcing channels, and engage in collaborative cost-management negotiations are better positioned to maintain continuity of supply and preserve development timelines under the altered trade environment.

Actionable segmentation-driven insight that ties product type, application focus, cell lineage, and packaging mode to procurement and validation priorities

A clear understanding of product and application segmentation is essential to align product development and procurement priorities with end-use requirements. Based on Product Type, market is studied across 2D Bags and 3D Bags, which delineates devices optimized for traditional planar processes and those engineered for advanced volumetric or scaffold-based culture respectively. Based on Application, market is studied across Biopharmaceutical Production and Research & Development. The Biopharmaceutical Production is further studied across Monoclonal Antibody Production, Recombinant Protein Production, and Vaccine Production. The Research & Development is further studied across Bioprocess Development, Monoclonal Antibody Research, and Stem Cell Research, a segmentation that clarifies how end-users prioritize attributes such as sterility assurance, scalability, and material compatibility depending on their process stage.

Based on Cell Type, market is studied across Insect and Mammalian. The Mammalian is further studied across CHO, Hybridoma, and NS0, and this distinction underscores the different biochemical and physical demands that each cell lineage places on media formulation and container materials. Based on Packaging Mode, market is studied across Bulk Bags and Single-Use Pre-Filled Bags, highlighting the operational trade-offs between centralized dispensing efficiency and convenience of pre-filled, ready-to-use formats. These segmentation pillars provide a framework for evaluating how product design and supplier services must adapt to meet specific performance, handling, and regulatory documentation requirements.

Interpreting commercial and technical decisions through these segmentation lenses enables more precise product alignment with process needs. It also supports targeted validation efforts by clarifying which attributes require prioritized testing for a given product-application-cell type-packaging combination. Consequently, product roadmaps and procurement specifications that incorporate these dimensions are better able to anticipate user pain points and to deliver solutions that integrate seamlessly with established workflows.

Regional dynamics and regulatory nuances that shape supplier qualification, inventory strategy, and operational continuity across global biomanufacturing hubs

Geography continues to shape strategic priorities, supplier selection, and regulatory engagement in the cell culture media bags space. In the Americas, investments in advanced biologics development and contract manufacturing capacity have driven demand for validated, scalable single-use systems; organizations in this region often emphasize rapid time-to-clinic and integrated supplier services. Conversely, Europe, Middle East & Africa presents a complex regulatory tapestry and a strong emphasis on compliance documentation and standardized quality systems, prompting suppliers to offer enhanced technical dossiers and region-specific regulatory support.

Asia-Pacific combines rapid capacity expansion with diverse manufacturing capabilities, where local production hubs and regional partnerships reduce lead times and offer cost advantages while also requiring nimble approaches to local certification and materials sourcing. Across these regions, differences in supplier ecosystems influence how companies structure sourcing strategies and invest in supplier qualification. The balance between centralized global procurement and regional qualification varies by organizational appetite for logistical complexity and the need for close regulatory alignment.

Understanding regional distinctions informs decisions about where to qualify alternative suppliers, how to tailor documentation for regulatory submissions, and what inventory strategies will most effectively mitigate logistical risk. Companies that align their supplier engagement and qualification timelines with these regional realities are better equipped to maintain continuity of operations and to accelerate development and manufacturing milestones across diverse geographies.

How supplier transparency, materials expertise, and integrated service models are creating competitive differentiation in single-use media delivery solutions

Leading suppliers in the cell culture media bags ecosystem are increasingly differentiating through a combination of technical documentation, materials science expertise, and integrated service offerings. Firms that invest in comprehensive extractables and leachables testing, compatibility matrices, and robust supply chain traceability gain distinct advantages when engaging with regulated manufacturers and contract organizations. These capabilities reduce downstream validation burden for customers and support faster uptake in production-critical applications.

In parallel, companies that provide configuration flexibility-such as multiple connector types, sterilization options, and pre-filled versus bulk packaging modalities-are better placed to serve a wider swath of end users. Strategic partnerships with materials suppliers and contract assemblers further strengthen vendor value propositions by enabling localized manufacturing and quicker response to specification changes. Additionally, suppliers that offer consultative support during process transfer and scale-up stages build deeper customer relationships and reduce friction during qualification cycles.

Competitive positioning increasingly hinges on transparency and collaboration. Vendors that publish detailed technical data, offer sample evaluation programs, and participate in cross-functional validation activities earn trust and facilitate adoption. For organizations procuring media delivery systems, prioritizing suppliers that combine rigorous science with flexible service models delivers tangible operational benefits and helps to future-proof bioprocess workflows.

Practical, high-impact recommendations to strengthen supplier resilience, validation efficiency, and operational agility for users of media delivery systems

Industry leaders should adopt a pragmatic program that balances immediate operational resilience with strategic capability building. First, prioritize diversification of qualified suppliers across different regions to reduce exposure to single points of failure; aligning supplier qualification timelines with regional regulatory expectations will accelerate parallel sourcing without inducing rework. Second, invest in deep technical due diligence that focuses on extractables and leachables profiles, material compatibility, and connector interoperability to minimize surprises during process transfer and scale-up.

Third, enhance inventory and procurement practices by aligning safety stock policies with product shelf-life and sterilization logistics; this reduces the risk of production interruptions while avoiding excessive storage costs. Fourth, cultivate collaborative relationships with suppliers that can provide localized assembly or filling to shorten lead times and simplify customs processes. Fifth, integrate procurement, quality, and process development teams early in supplier selection to ensure that technical validation and operational readiness proceed in parallel rather than in sequence.

Finally, pursue controlled pilot implementations of new bag formats in less critical production runs to validate handling, integration, and performance under real-world conditions before widespread deployment. These combined actions will strengthen supply resilience, improve time-to-deployment for new formats, and preserve the flexibility necessary to respond to evolving product and regulatory challenges.

A rigorous mixed-methods research approach combining technical interviews, materials evaluation, and supplier documentation cross-validation to inform practical decisions

The research approach underlying this report combines primary interviews with technical and procurement leaders, exhaustive review of materials science literature, and cross-validation of supplier technical documentation to ensure robustness of insights. Primary data collection included structured interviews with process development scientists, quality assurance leads, and procurement specialists to capture real-world constraints and priorities associated with container selection and qualification. This qualitative evidence was complemented by detailed analysis of publicly available technical reports and regulatory guidance documents to validate testing and documentation practices.

Materials compatibility and extractables and leachables evaluations were reviewed against industry best practices and regulatory expectations to assess common qualification pathways. Supplier service models and regional manufacturing footprints were examined through company filings and technical white papers to understand operational capabilities and logistical implications. Wherever possible, observations were triangulated across multiple sources to reduce bias and to emphasize reproducible operational lessons.

The methodology prioritizes actionable findings over abstract metrics, focusing on the implications of technology choices for validation timelines, supply chain risk, and process control. Limitations are acknowledged where proprietary data or emerging product evaluations constrain conclusive generalizations; in such cases, recommended follow-up activities are provided to guide targeted investigations and vendor trials.

A focused conclusion emphasizing the integrated importance of technical validation, supplier transparency, and supply chain resilience in decision-making

In sum, advancements in bag design, materials science, and regulatory expectations are collectively reshaping how organizations select and qualify media delivery systems. The interplay between technical performance, documentation rigor, and supply chain configuration now determines operational readiness as much as product specifications do. As a result, procurement decisions must be informed by a holistic view that includes compatibility testing, supplier transparency, regional qualification considerations, and contingency planning.

Organizations that proactively integrate technical assessment with strategic sourcing stand to reduce validation friction and improve continuity during scale-up. Similarly, vendors that prioritize scientific rigor, flexible configurations, and strong regional support are best positioned to meet the evolving needs of biologics developers and manufacturers. Moving forward, sustained focus on collaborative qualification practices and adaptable supply relationships will be essential to maintaining robust, reproducible processes across diverse applications and cell types.

Decision-makers should therefore treat media delivery system selection as a multi-dimensional choice that impacts development timelines, product quality controls, and operational resilience. By aligning procurement, quality, and process development around shared criteria and by engaging in early supplier collaboration, organizations can mitigate risk and accelerate the translation of lab-scale processes into reliable production systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cell Culture Media Bags Market, by Product Type

  • 8.1. 2D Bags
  • 8.2. 3D Bags

9. Cell Culture Media Bags Market, by Cell Type

  • 9.1. Insect
  • 9.2. Mammalian
    • 9.2.1. CHO
    • 9.2.2. Hybridoma
    • 9.2.3. NS0

10. Cell Culture Media Bags Market, by Packaging Mode

  • 10.1. Bulk Bags
  • 10.2. Single-Use Pre-Filled Bags

11. Cell Culture Media Bags Market, by Application

  • 11.1. Biopharmaceutical Production
    • 11.1.1. Monoclonal Antibody Production
    • 11.1.2. Recombinant Protein Production
    • 11.1.3. Vaccine Production
  • 11.2. Research & Development
    • 11.2.1. Bioprocess Development
    • 11.2.2. Monoclonal Antibody Research
    • 11.2.3. Stem Cell Research

12. Cell Culture Media Bags Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cell Culture Media Bags Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cell Culture Media Bags Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Cell Culture Media Bags Market

16. China Cell Culture Media Bags Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Avantor, Inc.
  • 17.6. BIOPAC
  • 17.7. CellBios Healthcare & Lifesciences Pvt Ltd
  • 17.8. Corning Incorporated
  • 17.9. Danaher Corporation
  • 17.10. Entegris, Inc.
  • 17.11. Eppendorf AG
  • 17.12. FUJIMORI KOGYO Co., Ltd.
  • 17.13. Greiner Bio-One International GmbH
  • 17.14. Lonza Group AG
  • 17.15. Meissner Filtration Products, Inc.
  • 17.16. Merck KGaA
  • 17.17. OriGen Biomedical, Inc.
  • 17.18. Parker Hannifin Corporation
  • 17.19. PBS Biotech, LLC
  • 17.20. Repligen Corporation
  • 17.21. Saint-Gobain Life Sciences
  • 17.22. Sartorius AG
  • 17.23. Thermo Fisher Scientific, Inc.
  • 17.24. Tofflon Life Science Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CELL CULTURE MEDIA BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CELL CULTURE MEDIA BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 2D BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 2D BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 2D BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 3D BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 3D BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 3D BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY INSECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY INSECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY INSECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY CHO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY CHO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY CHO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY HYBRIDOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY HYBRIDOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY HYBRIDOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY NS0, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY NS0, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY NS0, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BULK BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BULK BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BULK BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY SINGLE-USE PRE-FILLED BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY SINGLE-USE PRE-FILLED BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY SINGLE-USE PRE-FILLED BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY VACCINE PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY VACCINE PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 134. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 138. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 158. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 162. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 166. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 170. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 173. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)